The short version
22 companies supply this market — deep enough that no single failure threatens the supply.
Market view
mitomycin
58 marketed package NDCs · 22 active manufacturers
Most dispensed: 5 mg/10mL · Injection, Powder, Lyophilized, For Solution · #1 vial/carton / 10 ml in 1 vial · 40 mg/80mL · Injection, Powder, Lyophilized, For Solution · #1 vial, single-dose/carton / 80 ml in 1 vial, single-dose · 40 mg/80mL · Injection, Powder, Lyophilized, For Solution · #1 vial/box, unit-dose / 80 ml in 1 vial · 20 mg/40mL · Injection, Powder, Lyophilized, For Solution · #1 vial/carton / 40 ml in 1 vial
Same drug class
Other molecules FDA puts in Alkylating Drug, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Mitomycin in shortage right now?
- No. FDA does not currently list Mitomycin in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Mitomycin?
- 23 companies have marketed Mitomycin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.